Skip to main content
. 2017 Feb 22;13(4):2615–2622. doi: 10.3892/ol.2017.5760

Figure 2.

Figure 2.

Kaplan-Meier analysis of three-year overall survival in patients with glioma according to the expression levels of miR-130b in glioma tissues. (A) Cells with high miR-130b expression exhibited a significantly worse three-year survival compared with cells with low miR-130b expression. (B) miR-130b expression exerts a marked effect on the prognosis of patients in grade III or IV glioma. *P<0.05, by log-rank test. miR-130b, microRNA-130b.